Results 41 to 50 of about 359,306 (210)

Intra-Patient Genomic Variations of Human Papillomavirus Type 31 in Cervical Cancer and Precancer

Viruses, 2023
Human papillomavirus type 31 (HPV31) is detected less frequently in cervical cancer than two major causative types, HPV16 and HPV18. Here, we report a comprehensive analysis of HPV31 genome sequences in cervical lesions collected from Japanese women.
Gota Kogure, Kohsei Tanaka, Tomoya Matsui, Mamiko Onuki, Koji Matsumoto, Takashi Iwata, Iwao Kukimoto   +6 more
doaj   +1 more source

Validation of the WID‐CIN Methylation Test for Detection of Cervical Intraepithelial Neoplasia Grade 3 or Worse in an Independent Cohort

International Journal of Cancer, EarlyView.
ABSTRACT Many cervical screening programmes rely on cytology for triage of high‐risk human papillomavirus (hrHPV) positive women. However, cytological triage has variable and often limited sensitivity, and its availability can be restricted in resource‐poor settings.
Laura Burney Ellis, Sarah J. Bowden, Jack Tighe, Muhammad Habiburrahman, Katerina‐Vanessa Savva, Maria Paraskevaidi, Maria Nasioutziki, Chris J. Peters, James M. Flanagan, Maria Kyrgiou   +9 more
wiley   +1 more source

Checkpoint proteins in patients with precancer and cervical cancer [PDF]

, 2021
Abstract The efficiency of immuno-oncological drugs in treatment cervical cancer is not high. The research of new immunological targets in cervical cancer is actual. The aim was to study the local level of checkpoint proteins of immune cycle in patients with cervical cancer of different stages (sCD25, 4-1BB, B7.2, TGF-b1,
Elena Kayukova, Leonid Sholokhov, Tatiana Belokrinitskaya, Pavel Tereshkov   +3 more
openaire   +1 more source

Sociodemographic and clinical details of women (n = 6056) who underwent cervical precancer screening via HPV DNA testing using the careHPV, GeneXpert, AmpFire, or MA-6000 platforms.

, 2023
Sociodemographic and clinical details of women (n = 6056) who underwent cervical precancer screening via HPV DNA testing using the careHPV, GeneXpert, AmpFire, or MA-6000 platforms.
Bernard Hayford Atuguba (14809360), Comfort Mawusi Wormenor (14809357), Gifty Belinda Klutsey (15332571), Patrick Kafui Akakpo (11285560), Nana Owusu M. Essel (16446696), Edna Sesenu (15332574), Benjamin Tetteh Hansen (16883912), Stephen Danyo (14809363), Joseph Emmanuel Amuah (14809345), Seyram Kemawor (14809351), Kofi Effah (5816987), Isaac Gedzah (6889871), Ethel Tekpor (14809354)   +12 more
core   +1 more source

Lower Genital Tract Precancer and Cancer in Hematopoietic Cell Transplant Survivors and the Role of HPV: A Systematic Review and Future Perspectives

Clinical Hematology International, 2019
Female recipients of hematopoietic cell transplant (HCT) may develop lower genital tract (LGT) dysplasia or new malignancies. A comprehensive systematic review to delineate the occurrence and risk factors for post-HCT LGT precancer and cancer in women ...
Mohammad Shahrukh Tanweer, Mahmoud Aljurf, Bipin N. Savani, Perviz K. Iqbal, Shahrukh Hashmi   +4 more
doaj   +1 more source

Pelvic Ultrasound for Predicting Endometrial Neoplasia in Premenopausal Abnormal Uterine Bleeding

Journal of Ultrasound in Medicine, EarlyView.
Objectives Although ultrasound is the first line imaging modality for abnormal uterine bleeding (AUB), there is a lack of consensus on its predictiveness for premenopausal endometrial pathology. This study aims to determine the predictiveness of pelvic ultrasound for endometrial neoplasia and cancer precursor lesions in premenopausal patients ...
Jessica Grubman, Delaina Bling, Haania Kakwan, Shubhangi Mehra, April Gorman, Alicia Kiszka, Diego H. Castrillon, Elysia Moschos   +7 more
wiley   +1 more source

Distribution of HPV16 viral load in HPV16 positive cervical precancer and cancer lesions with respect to the level of pSTAT3 expression.

, 2019
Distribution of HPV16 viral load in HPV16 positive cervical precancer and cancer lesions with respect to the level of pSTAT3 expression.
Sutapa Mahata (434793), Shirish Shukla (383736), Bhudev Chandra Das (7349036), Kulbhushan Thakur (7349030), Seemi Farhat Basir (7349033), Alok Chandra Bharti (7349039), Mohit Jadli (7349027), Gauri Shishodia (434794)   +7 more
core   +1 more source

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA studyResearch in context

The Lancet Regional Health. Americas, 2023
Summary: Background: Cervical cytology remains widely used as the initial tool in cervical cancer screening worldwide. WHO guidelines recommend replacing cytology with primary HPV testing to reach cervical cancer elimination goals.
Arianis Tatiana Ramírez, Joan Valls, Armando Baena, Freddy David Rojas, Katherine Ramírez, Rodrigo Álvarez, Carmen Cristaldo, Odessa Henríquez, Adrián Moreno, Daysi Colque Reynaga, Hans González Palma, Isabel Robinson, Diana Carolina Hernández, Rosa Bardales, Lucia Cardinal, Yuly Salgado, Sandra Martínez, Emmanuel González, Diego Guillén, Laura Fleider, Silvio Tatti, Verónica Villagra, Gino Venegas, Aurelio Cruz-Valdez, Marleny Valencia, Guillermo Rodríguez, Carolina Terán, María Alejandra Picconi, Annabelle Ferrera, Elena Kasamatsu, Laura Mendoza, Alejandro Calderon, Silvana Luciani, Nathalie Broutet, Teresa Darragh, Maribel Almonte, Rolando Herrero, Mary Luz Rol, Eric Lucas, María de la Luz Hernández, Gloria Inés Sánchez, Raul Murillo, Jose Jerónimo, Catterina Ferreccio, María Isabel Rodríguez, Yessy Cabrera, Brenda Salgado, María Celeste Colucci, Maria Agustina Saino, Margarita Rodríguez de la Peña, Daniel Llanos Fernández, Laura García, Benedicta Caserta, Franco Doimi, Eduardo Lazcano-Ponce   +54 more
doaj   +1 more source

DNA‐Methylation for Risk‐Stratification of Women Without a Fully Visible Transformation Zone at Colposcopy: A Cross‐Sectional Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To evaluate the performance of DNA methylation markers for the detection of cervical precancer among screening‐positive older women without a fully visible transformation zone at colposcopy (TZ3). Design Cross‐sectional study. Setting Colposcopy clinics, Central Denmark Region, 2019–2021.
Karen Omann Binderup, Joachim Boers, Line Winther Gustafson, Berit Andersen, Lone Kjeld Petersen, Pinar Bor, Joost Gribnau, Wim G. V. Quint, Henk Van Den Munckhof, Mette Tranberg, Anne Hammer   +10 more
wiley   +1 more source

Multiclass discrimination of cervical precancers using Raman spectroscopy [PDF]

Journal of Raman Spectroscopy, 2008
AbstractRaman spectroscopy has the potential to differentiate among the various stages leading to high‐grade cervical cancer such as normal, squamous metaplasia, and low‐grade cancer. For Raman spectroscopy to successfully differentiate among the stages, an applicable statistical method must be developed.
Kanter, EM, Majumder, S, Vargis, Elizabeth, Robichaux-Viehoever, A, Kanter, G, Shappell, H, Jones, H, Mahadevan-Jansen, A   +7 more
openaire   +3 more sources